- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Patent holdings for IPC class A61P 1/00
Total number of patents in this class: 7263
10-year publication summary
|
239
|
420
|
481
|
570
|
649
|
676
|
722
|
518
|
533
|
251
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 10043 |
70 |
| Takeda Pharmaceutical Company Limited | 2718 |
49 |
| The Regents of the University of California | 20590 |
41 |
| DSM IP Assets B.V. | 5422 |
41 |
| Novartis AG | 10338 |
37 |
| Nestec S.A. | 2578 |
36 |
| Cedars-Sinai Medical Center | 1189 |
36 |
| N.V. Nutricia | 1088 |
36 |
| The Johns Hopkins University | 5844 |
30 |
| Glycom A/S | 248 |
30 |
| Eli Lilly and Company | 4050 |
28 |
| Janssen Pharmaceutica N.V. | 3213 |
27 |
| Pfizer Inc. | 3375 |
27 |
| Raqualia Pharma Inc. | 123 |
27 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3333 |
26 |
| F. Hoffmann-La Roche AG | 7847 |
25 |
| Janssen Biotech, Inc. | 1738 |
25 |
| Centre National de La Recherche Scientifique | 10914 |
24 |
| Osaka University | 3289 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
23 |
| Other owners | 6601 |